Abstract
Introduction: Animal model of temporal lobe epilepsy (TLE) provide an essential platform to study the disease pathophysiology, and disease modifying management protocols. Lithium –pilocarpine model is one of the most favored model. Many practical difficulties have been encountered while creating this model in this study as well as by other authors. We have systematically attempted to compile all issues and their possible solutions in establishment of Li-Pi model of status epilepticus in wistar rats, to provide a dependable protocol with improved seizure induction rates and lower mortality rates. Materials and Methods: Young small size male wistar rats (100-150gm) were injected with lithium chloride (LiCl) (127 mg/kg, i.p.), followed by methyl scopolamine (1mg/kg, i.p.) after 18-22 hrs. Precisely after 30 minutes, dose of pilocarpine (i.p.) was administered. Post seizures, diazepam (10 mg/kg) was injected to reduce seizures severity and to increase survival rate and rats were fed glucose (10% of body weight) through oral gavage. Model creation was validated by histological examination of hippocampus. The rats which did not develop seizures, were reutilized for the model generation after drug wash-out period of 48 hours. Results: Initial model creation was unsuccessfully attempted in 75 rats. Standard described protocol of three incremental doses of pilocarpine (10mg/kg, maximum of 30mg/kg) did not elicit epilepsy. Loading dose of 30mg/kg pilocarpine caused stage 1 epilepsy in 60% rats; second dose of pilocarpine (30mg/kg), caused stage 2 epilepsy in 70% rats. Successful TLE model creation was seen in 33 out of 57 rats, using proposed modification in which 2 incremental doses of pilocarpine (30mg/kg each) were followed by 3 doses of 10mg/kg each; 6 rats died. Conclusions: The study provides a detailed procedure for lithium pilocarpine model creation and various pitfalls encountered. Modified pilocarpine dosage led to improved seizure induction rates (58%) and lower mortality rates (10%). Keywords: Epilepsy animal model; Status epilepticus; lithium-pilocarpine; Animal mortality
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.